Dyslipidemia Archives - The Cardiology Advisor


low density lipid particle and receptor

Adding PCSK9i to Niacin Therapy Reduces Lp(a) Concentrations

Adding proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) to background niacin therapy is shown to reduce lipoprotein(a) [Lp(a)] by approximately 15%, according to study results published in the Journal of Clinical Lipidology. In this study, 150 patients were divided into 2 groups: 136 received PCSK9i monotherapy and 14 received PCSK9i and niacin combination therapy. PCSK9i…

Next post in Dyslipidemia